bpc 157 human clinical trials evidence 2024 review What Orthopedic Surgeons Should Know About Therapeutic Peptides BPC-157 as an Investigational Peptide
Description
Inhibit osteoclast activation and differentiation, reduce bone resorption Block osteoclast differentiation signal RANKL/RANK/OPG pathway: AOD 9604 downregulates the expression of RANKL (a key factor in osteoclast differentiation) and upregulates the expression of OPG (a RANKL antagonist), reducing the RANKL/OPG ratio by 50-60% and blocking the differentiation of osteoclast precursors into mature osteoclasts
Why not just use sterile water
The same drug was given later that ran for 30 mins, would that a justify using 96366, the drug does not have to run for at least 31 minutes
Gastroenterology 146 , 726735 (2014)
Researchers should apply a consistent standard when sourcing this compound for laboratory use
Head over to the Pet Matrx store to learn more
